Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 6 to 10, 2022.

Combining clinical, translational and basic research, the meeting brings together leading breast cancer researchers and clinicians, helping to shape clinical practices and research directions. The international conference returns to an in-person format in San Antonio, Texas, with researchers and physicians attending from over 90 countries.

The mission of the annual conference, which began in 1977 as a one-day regional conference, is for experts in the field of breast cancer research and treatment to share the latest information about the biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease.

The symposium is presented by the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine.

This year’s scientific program features numerous presentations and updates on new and late-breaking data, including diagnostic developments by breast experts at the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).